Author

Adam P. Matson

UConn Health;ORCID 0000-0003-4080-0013Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 2 Assay:whole-genome sequencing· 2 Organism:bacteria (other)· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

André A. Grassmann· 1 shared Anthony A. ProvatasiD· 1 shared Cameron King· 1 shared Elizabeth A. WerreniD· 1 shared Jessica M. EwaldiD· 1 shared Justin D. Radolf· 1 shared Katrin Unterhauser· 1 shared Louisa KalsneriD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

André A. Grassmann

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The MarR-family regulator TilR links biosynthesis of enterotoxin tilimycin with physiologic adaptation in Klebsiella oxytoca

Katrin Unterhauser, André A. Grassmann, Parithi Balachandran, Anthony A. Provatas, Yanjiao Zhou, Melissa J. Caimano, Justin D. Radolf, Adam P. Matson

This study identifies TilR, a MarR-family regulator in Klebsiella oxytoca, as a repressor of tilimycin biosynthesis and links it to metabolic and virulence-related gene expression.

bioRxiv · Nov 7, 2026 · PreprintMicrobiology

A de novo variant in PAK2 detected in an individual with Knobloch type 2 syndrome

Elizabeth A. Werren, Louisa Kalsner, Jessica M. Ewald, Michael Peracchio, Cameron King, Purva Vats, Peter A. Audano, Peter N. Robinson, Mark D. Adams, Melissa A. Kelly, Adam P. Matson

The paper identifies a novel de novo PAK2 variant in a patient with Knobloch syndrome type 2, supporting PAK2's role in the disorder and expanding its clinical features.

American Journal of Medical Genetics Part A · Jan 28, 2025Peer-reviewedGenomics